Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

19 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Soluble Fas is a marker of peripheral arterial occlusive disease in haemodialysis patients
Masse M, et al. Nephrol Dial Transplant 2002. Among authors: Vigneault N. PMID 11865097
RESULTS: Compared with subjects without evidence of disease (n=56), subjects with PAOD (n=51) had significantly higher plasma levels of sFas (30.0+/-8.9 vs 26.4+/-9.5 ng/ml; P=0.04). ...
RESULTS: Compared with subjects without evidence of disease (n=56), subjects with PAOD (n=51) had significantly higher plasma …
Soluble Fas is a marker of coronary artery disease in patients with end-stage renal disease
Hébert MJ, et al. Am J Kidney Dis 2001 - Clinical Trial. Among authors: Vigneault N. PMID 11728960
Plasma levels of sFas were significantly greater (P = 0.04) among subjects with (n = 64) than without evidence of CAD (n = 43). ...
Plasma levels of sFas were significantly greater (P = 0.04) among subjects with (n = 64) than without evidence of CAD (n = 43) …
The phospholipase A2 of human spermatozoa; purification and partial sequence
Langlais J, et al. Biochem Biophys Res Commun 1992. Among authors: Vigneault N. PMID 1731781
Sequence analysis of the N-terminal portion of the molecule revealed the identity of the first 19 amino acids to be YNYQFGLMIVITKGHFAMV. ...
Sequence analysis of the N-terminal portion of the molecule revealed the identity of the first 19 amino acids to be YNYQFGLMIVITKGHFA …
19 results
Jump to page
Feedback